Roivant Sciences Ltd. Quarterly Operating Income (Loss) in USD from Q2 2020 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Roivant Sciences Ltd. quarterly/annual Operating Income (Loss) history and growth rate from Q2 2020 to Q2 2024.
  • Roivant Sciences Ltd. Operating Income (Loss) for the quarter ending June 30, 2024 was -$120M, a 56.5% increase year-over-year.
  • Roivant Sciences Ltd. Operating Income (Loss) for the twelve months ending June 30, 2024 was $4.4B.
  • Roivant Sciences Ltd. annual Operating Income (Loss) for 2023 was $4.24B.
  • Roivant Sciences Ltd. annual Operating Income (Loss) for 2022 was -$1.18B, a 13% increase from 2021.
  • Roivant Sciences Ltd. annual Operating Income (Loss) for 2021 was -$1.35B, a 26.2% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $4.4B -$120M +$156M +56.5% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-09
Q1 2024 $4.24B -$266M -$31.8M -13.6% Jan 1, 2024 Mar 31, 2024 10-K 2024-05-30
Q4 2023 $4.27B $5.06B +$5.44B Oct 1, 2023 Dec 31, 2023 10-Q 2024-02-13
Q3 2023 -$1.17B -$276M +$4.31M +1.54% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-13
Q2 2023 -$1.17B -$276M +$5.9M +2.09% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-09
Q1 2023 -$1.18B -$234M +$32.6M +12.2% Jan 1, 2023 Mar 31, 2023 10-K 2024-05-30
Q4 2022 -$1.21B -$378M -$132M -53.7% Oct 1, 2022 Dec 31, 2022 10-Q 2024-02-13
Q3 2022 -$1.08B -$281M +$404M +59% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 -$1.48B -$282M -$128M -82.9% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 -$1.35B -$267M +$274M +50.7% Jan 1, 2022 Mar 31, 2022 10-K 2023-06-28
Q4 2021 -$1.63B -$246M +$13M +5.04% Oct 1, 2021 Dec 31, 2021 10-Q 2023-02-13
Q3 2021 -$1.64B -$684M -$528M -337% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$1.11B -$154M -$39.9M -34.9% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 -$1.07B -$541M Jan 1, 2021 Mar 31, 2021 10-K 2022-06-28
Q4 2020 -$259M Oct 1, 2020 Dec 31, 2020 10-Q 2022-02-14
Q3 2020 -$157M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 -$114M Apr 1, 2020 Jun 30, 2020 10-Q 2021-09-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.